Chinese Academy of Sciences Innovation and Investment Company

Chinese Academy of Sciences Innovation and Investment Company (CAS Innovation) is a state-owned venture capital and investment firm established in 2015 under CASH to commercialize CAS research, with a strong emphasis on biomedicine and life sciences. It partners with entities like HUYA Bioscience for global development of CAS-discovered biomedical innovations. As part of China's national strategy, it supports biotech industrialization through investments in early- and growth-stage high-tech companies. No evidence of drug development pipelines, clinical programs, or public trading; it functions as an investor and incubator rather than a traditional biotech/pharma company.